<DOC>
	<DOC>NCT00277732</DOC>
	<brief_summary>The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).</brief_summary>
	<brief_title>Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>4575 years Body Mass Index &gt;= 25 Diabetes treatment for at least 12 months Regular visitors of the participating community pharmacy Patients taking only insulin (no oral antidiabetic drugs)</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>